{"version":"1.0","provider_name":"MedCity INVEST PharmaTech","provider_url":"https:\/\/events.medcitynews.com\/invest-pharmatech","author_name":"eclements","author_url":"https:\/\/events.medcitynews.com\/invest-pharmatech\/author\/eclements\/","title":"Habib Dable - MedCity INVEST PharmaTech","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"K9ygQwKWXs\"><a href=\"https:\/\/events.medcitynews.com\/invest-pharmatech\/speakers\/habib-dable\/\">Habib Dable<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/events.medcitynews.com\/invest-pharmatech\/speakers\/habib-dable\/embed\/#?secret=K9ygQwKWXs\" width=\"600\" height=\"338\" title=\"&#8220;Habib Dable&#8221; &#8212; MedCity INVEST PharmaTech\" data-secret=\"K9ygQwKWXs\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/events.medcitynews.com\/invest-pharmatech\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/events.medcitynews.com\/uploads\/sites\/3\/2016\/05\/Habib2.jpg","thumbnail_width":200,"thumbnail_height":200,"description":"Habib Dable is president of U.S. pharmaceuticals for Bayer, a role he has held since October 2015. Previously, Habib was global head of specialty medicine for Bayer overseeing four therapeutic areas \u2013 hematology, oncology, ophthalmology, and neurology. Habib started at Bayer in 1994 as a sales representative and has held several sales, marketing, and strategic&hellip;"}